These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 824086)

  • 1. Etidronate disodium in postmenopausal osteoporosis.
    Heaney RP; Saville PD
    Clin Pharmacol Ther; 1976 Nov; 20(5):593-604. PubMed ID: 824086
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Sodium etidronate (EHDP) and osteoporosis].
    Nuti R; Righi G; Turchetti V; Vattimo A
    Clin Ter; 1981 Oct; 99(1):33-42. PubMed ID: 6171376
    [No Abstract]   [Full Text] [Related]  

  • 3. Focal mineralization defect during disodium etidronate treatment of calcinosis.
    Weinstein RS
    Calcif Tissue Int; 1982 May; 34(3):224-8. PubMed ID: 6809282
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Effect of etidronate disodium (EHDP) on calcium oxalate renal stones induced by synthetic 1 alpha(OH) vitamin D3 and ethylene glycol in rats].
    Kawamura J; Nonomura M; Okada Y; Yoshida O; Takashima M; Itokawa Y
    Hinyokika Kiyo; 1985 May; 31(5):749-62. PubMed ID: 3931444
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Fibrodysplasia (myositis) ossificans progressiva treated with disodium etidronate.
    Hentzer B; Jacobsen HH; Asboe-Hansen G
    Clin Radiol; 1978 Jan; 29(1):69-75. PubMed ID: 414874
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cyclic therapy of osteoporosis with neutral phosphate and brief, high-dose pulses of etidronate.
    Mallette LE; LeBlanc AD; Pool JL; Mechanick JI
    J Bone Miner Res; 1989 Apr; 4(2):143-8. PubMed ID: 2499164
    [TBL] [Abstract][Full Text] [Related]  

  • 7. An apparent 1,25-dihydroxyvitamin D-independent stimulation of intestinal calcium absorption in patients with Paget disease of bone during a short-term diphosphonate therapy.
    Norman DA; Zerwekh JE; Pak CY
    Metabolism; 1981 Mar; 30(3):290-2. PubMed ID: 6782425
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The effect of 1 alpha-hydroxyvitamin D3 on the mineralization defect in disodium etidronate-treated Paget's disease--a double-blind randomized clinical study.
    Ralston SH; Boyce BF; Cowan RA; Fogelman I; Smith ML; Jenkins A; Boyle IT
    J Bone Miner Res; 1987 Feb; 2(1):5-12. PubMed ID: 3137773
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of etidronate disodium on bone turnover following surgical menopause.
    Smith ML; Fogelman I; Hart DM; Scott E; Bevan J; Leggate I
    Calcif Tissue Int; 1989 Feb; 44(2):74-9. PubMed ID: 2492893
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Changes in the renal and extrarenal handling of phosphate induced by disodium etidronate (EHDP) in man.
    Walton RJ; Russell RG; Smith R
    Clin Sci Mol Med; 1975 Jul; 49(1):45-56. PubMed ID: 807449
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [A one-year prospective study of disodium etidronate versus 17 beta estradiol in the prevention of postmenopausal osteoporosis].
    Chaouat D; Belange G; Danan S; De Vernejoul MC; Faures Quenet B; Chaouat Y
    Rev Rhum Ed Fr; 1993 May; 60(5):353-8. PubMed ID: 8167642
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Therapeutic effects of 25-hydroxycholecalciferol and sodium etidronate on renal osteodystrophy.
    Zucchelli P; Catizone L; Casanova S; Fabbri L; Fusaroli M
    Miner Electrolyte Metab; 1982 Feb; 7(2):86-96. PubMed ID: 6820473
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Biochemical effects of a calcium supplement in osteoporotic postmenopausal women with normal absorption and malabsorption of calcium.
    Need AG; Horowitz M; Philcox JC; Nordin BE
    Miner Electrolyte Metab; 1987; 13(2):112-6. PubMed ID: 3696089
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Action of 1,25-dihydroxyvitamin D3 and a diphosphonate on calcium metabolism in rats.
    Bonjour JP; Trechsel U; Fleisch H; Schenk R; DeLuca HF; Baxter LA
    Am J Physiol; 1975 Aug; 229(2):402-8. PubMed ID: 808969
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Spontaneous fractures of uninvolved bones in patients with Paget's disease during unduly prolonged treatment with disodium etidronate (EHDP).
    Mautalen C; Gonzalez D; Blumenfeld EL; Santini Araujo E; Schajowicz F
    Clin Orthop Relat Res; 1986 Jun; (207):150-5. PubMed ID: 3087670
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Bone remodeling and calcium metabolism: a correlated histomorphometric, calcium kinetic, and biochemical study in patients with osteoporosis and Paget's Disease.
    Lauffenburger T; Olah AJ; Dambacher MA; Guncaga J; Lentner C; Haas HG
    Metabolism; 1977 Jun; 26(6):589-606. PubMed ID: 404501
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [EHDP (ethylidene-1-hydroxy-1,1-diphosphonate) in the treatment of polyosseous Paget disease].
    Kovarik J; Niebauer B; Woloszczuk W; Frühwald F; Kolbe H
    Wien Klin Wochenschr; 1985 Mar; 97(7):311-5. PubMed ID: 3922124
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Duration of etidronate effect demonstrated by serial bone scintigraphy.
    Sandler ED; Parisi MT; Hattner RS
    J Nucl Med; 1991 Sep; 32(9):1782-4. PubMed ID: 1908891
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A strategy for the management of elderly women with primary hyperparathyroidism: a comparison of etidronate therapy with parathyroidectomy.
    Horiuchi T; Onouchi T; Inoue J; Shionoiri A; Hosoi T; Orimo H
    Gerontology; 2002; 48(2):103-8. PubMed ID: 11867933
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Effects of etidronate disodium (EHDP) on urogenital malignancies with bone metastasis: a multicentered collaborative evaluation].
    Kawamura J; Tochigi H; Yanagawa M; Yoshida O; Hida S; Mori O; Suzuki N; Saito K; Komatsu Y; Hatayama T
    Hinyokika Kiyo; 1988 Mar; 34(3):528-37. PubMed ID: 3133934
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.